STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · Real-Time Price · USD
2.620
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
STRATA Skin Sciences Revenue
In the year 2024, STRATA Skin Sciences had annual revenue of $33.56M with 0.61% growth. STRATA Skin Sciences had revenue of $9.58M in the quarter ending December 31, 2024, with 10.21% growth.
Revenue (ttm)
$33.56M
Revenue Growth
+0.61%
P/S Ratio
0.29
Revenue / Employee
$316,623
Employees
106
Market Cap
10.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.56M | 204.00K | 0.61% |
| Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
| Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
| Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
| Dec 31, 2020 | 23.09M | -8.50M | -26.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
SSKN News
- 4 weeks ago - STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 weeks ago - STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update - GlobeNewsWire
- 5 weeks ago - STRATA Skin Sciences Highlights New Clinical Study from Japan Demonstrating Superiority of Narrow Band Excimer Laser Over Non Narrow Band UVB-Source Like Excimer Light - GlobeNewsWire
- 5 months ago - STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference - GlobeNewsWire
- 5 months ago - STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 months ago - STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group - GlobeNewsWire